Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial Transcript
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial March 16, 2026 4:30 PM EDTCompany ParticipantsDavid...

Source: Seeking Alpha
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial March 16, 2026 4:30 PM EDTCompany ParticipantsDavid...